Suppr超能文献

脊髓性肌萎缩症上下肢运动评估中最小临床重要差异的计算

Calculation of the Minimal Clinically Important Difference in Upper and Lower Limb Motor Assessment in Spinal Muscular Atrophy.

作者信息

Hara Takatoshi, Miyazaki Yuta, Shimizu-Motohashi Yuko, Nishida Daisuke, Kamimura Akiko, Takeuchi Mizuki, Ariake Yosuke, Tsubouchi Ayaka, Inaba Tasuku, Kawaguchi Taiyo, Komaki Hirofumi, Abo Masahiro

机构信息

Department of Rehabilitation Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Department of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo, Japan.

出版信息

Prog Rehabil Med. 2025 Jan 8;10:20250001. doi: 10.2490/prm.20250001. eCollection 2025.

Abstract

OBJECTIVES

Physical function assessments in patients with spinal muscular atrophy (SMA) are important indicators for assessing the effectiveness of treatment and changes over time in rehabilitation therapy. However, few reports exist on this indicator. This study calculated the minimal clinically important difference (MCID) for assessing motor function in the upper and lower limbs of individuals with SMA to estimate the degree of change within a functional score that is considered clinically meaningful.

METHODS

This cohort study relied on individual participant measurements. A distribution-based approach was used to calculate the MCID values, incorporating data from 26 patients with SMA for the 6-Minute Walk Test (6MWT), Hammersmith Functional Motor Scale Expanded (HFMSE), Revised Upper Limb Module (RULM), and grip and pinch strength.

RESULTS

The standard errors of measurement for all patients were: 58.38 m for 6MWT; 4.71 points for HFMSE; 3.25 points for RULM; 10.93 N and 9.86 N for right and left grip strength, respectively; 5.42 N and 4.73 N for right and left Palmar pinch; and 11.96 N and 8.66 N for right and left Key pinch. Significant correlations were observed between the physical function assessments.

CONCLUSIONS

We calculated MCID values for physical function evaluations of SMA and, as a sub-analysis, determined the SMA type and ambulatory status. These findings are expected to contribute to future SMA treatment and rehabilitation and promote the selection of appropriate physical function assessments.

摘要

目的

脊髓性肌萎缩症(SMA)患者的身体功能评估是评估治疗效果及康复治疗随时间变化的重要指标。然而,关于该指标的报道较少。本研究计算了评估SMA患者上下肢运动功能的最小临床有意义差异(MCID),以估计功能评分中被认为具有临床意义的变化程度。

方法

本队列研究依赖个体参与者测量。采用基于分布的方法计算MCID值,纳入了26例SMA患者在6分钟步行试验(6MWT)、哈默史密斯功能运动量表扩展版(HFMSE)、修订上肢模块(RULM)以及握力和捏力方面的数据。

结果

所有患者的测量标准误差分别为:6MWT为58.38米;HFMSE为4.71分;RULM为3.25分;右手和左手握力分别为10.93牛和9.86牛;右手和左手掌捏力分别为5.42牛和4.73牛;右手和左手钥匙捏力分别为11.96牛和8.66牛。身体功能评估之间存在显著相关性。

结论

我们计算了SMA身体功能评估的MCID值,并作为一项亚分析确定了SMA类型和步行状态。这些发现有望为未来的SMA治疗和康复做出贡献,并促进合适的身体功能评估的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc79/11704608/f580d2566bc1/prm-10-20250001-g001.jpg

相似文献

1
Calculation of the Minimal Clinically Important Difference in Upper and Lower Limb Motor Assessment in Spinal Muscular Atrophy.
Prog Rehabil Med. 2025 Jan 8;10:20250001. doi: 10.2490/prm.20250001. eCollection 2025.
2
Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis.
Neurol Ther. 2024 Oct;13(5):1483-1504. doi: 10.1007/s40120-024-00653-2. Epub 2024 Sep 2.
3
Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.
Eur J Neurol. 2020 Dec;27(12):2586-2594. doi: 10.1111/ene.14472. Epub 2020 Sep 6.
10

本文引用的文献

2
Spinal muscular atrophy.
Nat Rev Dis Primers. 2022 Aug 4;8(1):52. doi: 10.1038/s41572-022-00380-8.
3
Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.
Eur J Neurol. 2020 Dec;27(12):2586-2594. doi: 10.1111/ene.14472. Epub 2020 Sep 6.
4
Muscle strength and motor function in adolescents and adults with spinal muscular atrophy.
Neurology. 2020 Oct 6;95(14):e1988-e1998. doi: 10.1212/WNL.0000000000010540. Epub 2020 Jul 30.
6
Test-retest reliability of tip, key, and palmar pinch force sense in healthy adults.
BMC Musculoskelet Disord. 2020 Mar 26;21(1):189. doi: 10.1186/s12891-020-3187-7.
7
Outcome measures in a cohort of ambulatory adults with spinal muscular atrophy.
Muscle Nerve. 2020 Feb;61(2):187-191. doi: 10.1002/mus.26756. Epub 2019 Dec 11.
8
Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy.
Support Care Cancer. 2019 Dec;27(12):4753-4762. doi: 10.1007/s00520-019-04771-8. Epub 2019 Apr 10.
9
Physical exercise training for type 3 spinal muscular atrophy.
Cochrane Database Syst Rev. 2019 Mar 1;3(3):CD012120. doi: 10.1002/14651858.CD012120.pub2.
10
Revised upper limb module for spinal muscular atrophy: 12 month changes.
Muscle Nerve. 2019 Apr;59(4):426-430. doi: 10.1002/mus.26419. Epub 2019 Feb 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验